Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:10 PM
Ignite Modification Date:
2025-12-24 @ 9:10 PM
NCT ID:
NCT06857604
Eligibility Criteria:
Inclusion Criteria:
1. Patients age \< 25 years
2. Patients with diagnosed autoimmune cytopenias (AIC), polyclonal lymphoproliferation (PL), lymphoma (ML), bone marrow failure, and myelodysplastic syndrome (BMF/MDS) (see details below)
3. Signed Informed Consent
Exclusion Criteria:
1. Patients with Lymphoma secondary to HIV or transplant
2. Patient with self-resolving or post-infective AICs
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
25 Years
Study:
NCT06857604
Study Brief:
Protocol Section:
NCT06857604